IPO Premiums
IPO calendar
APListed

Asston Pharmaceuticals Limited

Bookbuilding IPO · BSE

Price band
₹115 - ₹123
Lot size
1,000 shares
Issue amount
₹27.56 cr
Total subscription
186.59×
Current price₹112.9
Listing price ₹119
Watch live price ↗
Opens
9 Jul 2025
Closes
11 Jul 2025
Allotment
14 Jul 2025
Listing
16 Jul 2025

Offer at a glance

Issue overview

Issue size
22,41,000 shares
Face value
₹10 per share
Minimum investment
₹1,15,000
Fresh issue
₹27.56 cr
Offer for sale
₹0 cr
Registrar
Maashitla Securities Private Limited
Listing exchange
BSE
Maximum investment
₹1,23,000
Issue type
Bookbuilding IPO
Shares before issue
62,71,360
Shares after issue
85,12,360

Lot sizes

CategoryLotsSharesAmount
RETAIL22,000₹2,46,000
sHNI33,000₹3,69,000
bHNI99,000₹11,07,000

Share reservation

RETAIL33.29%
BHNI9.58%
SHNI4.79%
Anchor28.34%
QIB18.96%
MARKET MAKER5.04%

Subscription & GMP

Subscription by category

Total subscribed186.59×

Missing multiples are calculated from bids and offered shares when available.

QIB85.76×
NIB353.15×
HNIs(10L +)423.95×
HNIs (2-10L)208.93×
RETAIL172.14×

GMP history

015304 Jul: ₹108 Jul: ₹109 Jul: ₹2010 Jul: ₹3011 Jul: ₹3014 Jul: ₹2215 Jul: ₹2516 Jul: ₹2612 Nov: ₹261 Jun: ₹2623 Sept: ₹26
4 Jul₹2623 Sept

Application-wise demand

CategoryReserved applicationsApplied applications
RETAIL37364,208
HNIs(10L +)728,616
HNIs (2-10L)366,457

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs5.230
RETAIL9.181.16
HNIs 2+1.330.34
HNIs 10+2.640

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
0102030Mar-22 · Revenue: 7.19Mar-22 · Profit after tax: 1.06Mar-22Mar-23 · Revenue: 15.84Mar-23 · Profit after tax: 1.36Mar-23Mar-24 · Revenue: 25.61Mar-24 · Profit after tax: 4.33Mar-24Mar-25 · Revenue: 6.21Mar-25 · Profit after tax: 1.32Mar-25
RevenueProfit after tax

Key performance indicators

MetricMar-25Mar-24Mar-23
EPS2.116.92.37
ROE69.7350.5632.47
ROCE79.4651.2534.29
RONW40.3621.2853.21
PRE IPO(PE)017.830
POST IPO(PE)13.200

Values and labels as reported in the issue data.

Company information

Company profile

Asston Pharmaceuticals Limited, established in 2019, is a pharmaceutical company focused on exporting healthcare products worldwide. It offers a wide range of products, including tablets, capsules, sachets, and syrups. These cover various therapeutic areas such as pain relief, antibiotics, antifungals, vitamins, and more. The company manufactures medicines for its own sales as well as on a contract basis, mainly working directly with different marketers. It holds certifications from both Central and State FDA, along with NQA accreditation, and follows Quality Management System standards to maintain product quality. As of July 3, 2025, the company employs 46 permanent staff and 6 contractual workers across different departments.

Strengths

  • Strong Focus on Formulation and R&D – Specializes in developing high-quality medicines that meet international standards.
  • Experienced and Skilled Management Team – Led by industry professionals with deep knowledge and a track record of business growth.
  • Diverse Product Portfolio with Strategic Manufacturing – Offers a wide variety of products and operates plants near major export locations for easy distribution.

Risk factors

  • Risk of Regulatory Issues – Works in a highly regulated industry; any non-compliance can affect operations and reputation.
  • Dependency on Other Manufacturers – Relies on third-party makers for some products, which may impact quality and supply flow.
  • Heavy Dependence on Key Clients – Large part of income depends on a few customers; losing them can affect business growth.

Promoters

Dr. Ashish Narayan Sakalkar

Saili Jayaram More

Sachin Chandrakant Badakh

Registrar & documents

Lead manager

Sobhagya Capital Options Limited

Registered office

4th Floor, Office No. A-431 Balaji Bhavan, Plot No 42A Sector-11 CBD Belapur, Navi Mumbai, Thane Navi Mumbai, Maharashtra, 400614

+91 22 49731411

[email protected]Company website ↗

Frequently Asked Questions

What is Asston Pharmaceuticals IPO GMP today?

As of today, Asston Pharmaceuticals IPO Grey Market Premium (GMP) is reported at +₹26 per share. Based on the upper price band of ₹123, the estimated listing price is ₹149 (+21.1% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Asston Pharmaceuticals IPO?

The minimum bid lot size for Asston Pharmaceuticals IPO is 1,000 shares. At the cut-off price of ₹123 per share, retail investors need a minimum application amount of ₹1,23,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Asston Pharmaceuticals IPO allotment status be announced?

The allotment status for Asston Pharmaceuticals IPO is scheduled to be finalized on 14 Jul 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Maashitla Securities Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Asston Pharmaceuticals IPO allotment status online by PAN?

To check Asston Pharmaceuticals IPO allotment status: 1) Visit the registrar portal (Maashitla Securities Private Limited) or the BSE IPO allotment page. 2) Select 'Asston Pharmaceuticals Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.